Drug intelligence / Profile preview

nitenpyram

Development stage
Unknown
Lead developer
Sumitomo Chemical
Modality
Small Molecules
Administration
Oral
01

Overview

Nitenpyram is a small molecule neonicotinoid insecticide used primarily in veterinary medicine to treat adult flea infestations in dogs and cats. It acts as a neurotoxin by binding to and blocking nicotinic acetylcholine receptors in the central nervous system of insects, leading to paralysis and rapid death of adult fleas. Nitenpyram is administered orally as a tablet and begins killing fleas within 30 minutes of administration; it achieves over 90% effectiveness against adult fleas on dogs within 4 hours and on cats within 6 hours. Its effects last for about 24–48 hours. Nitenpyram does not affect flea eggs or larvae and does not provide long-term prevention but is valued for its rapid action against existing infestations[1][2][3][5][7].

Brand names
CapstarBestguardCapguardPetArmor FastCaps
02

Targets

Nicotinic Acetylcholine Receptor

Beyond the preview

Go deeper on nitenpyram.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nitenpyram.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call